Antibody response in healthcare workers vaccinated with live-attenuated recombinant Japanese encephalitis chimeric vaccine

Not Applicable

Recruiting

• Conditions: Japanese encephalitis risk; Japanese encephalitis; antibody response; vaccination; adults; healthcare workers; Thailand

• Registration Number: TCTR20151203001
• Lead Sponsor: Sanofi Pasteur, Thailand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-12-01
• Study Start: 2015-12-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

Medical personnel who have risk factors of inadequate JE antibody, and voluntarily join the study

Exclusion Criteria

- Who did not provided informed consent to a blood test
- People with high fever, acute illness
- People with a history of allergy vaccines
- Patients with chronic diseases such as heart, liver, kidney, which is in severe or complications within one year
- who are immunocompromised, women during lactation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
levels of antibody response vaccinated Japanese encephalitis Upon enrollment Blood samples for levels of antibodies after vaccination against Japanese encephalitis

Secondary Outcome Measures

Name	Time	Method
proportion and predictors of antibody response Upon enrollment dates and levels of antibody response